Related Experiment Videos
Apoptosis-new clues to the pathogenesis of Sjögren's syndrome?
Rheumatology (Oxford, England)
|March 21, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
Neuropathology and applied neurobiology·2018
Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
Neuropathology and applied neurobiology·2018
Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Annals of the rheumatic diseases·2017
Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis.
Archives of dermatological research·2016
Predicting relapse in pediatric IgA vasculitis in the era of machine learning: an explainable hybrid ensemble model.
Rheumatology (Oxford, England)·2026
Timing matters: diagnostic delay and major organ involvement in Behçet's syndrome.
Rheumatology (Oxford, England)·2026
Treat-to-target: LLDAS, DORIS remission, and flare prevention strategies.
Rheumatology (Oxford, England)·2026
Outcomes of intensive care patients with acute small-vessel vasculitis: a 23-year single-centre experience.
Rheumatology (Oxford, England)·2026
Early mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study.
Rheumatology (Oxford, England)·2026
Ezetimibe/bempedoic acid combination in statin-induced anti-HMGCR positive immune-mediated necrotizing myopathy: a case series.
Rheumatology (Oxford, England)·2026
Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.
medRxiv : the preprint server for health sciences·2026
The therapy-conditioned host: a state-transition framework for second primary cancer evolution.
Frontiers in oncology·2026